Co-Diagnostics, Inc.: annual meeting had no quorum

What happened

• The company reported that its Annual Meeting of Stockholders, originally held on Sep 3, 2026, was adjourned because a quorum was not present or represented.
• The Annual Meeting was reconvened on Sep 24, 2026 and Sep 30, 2026, but a quorum was not present or represented on either date, and it was adjourned to Oct 14, 2026.
• On Oct 14, 2026 the company reconvened the Annual Meeting and reported that a quorum was not present or represented and it was therefore unable to transact business; the company determined not to adjourn the meeting again.

Key details

• Dates: Sep 3, 2026; Sep 24, 2026; Sep 30, 2026; Oct 14, 2026.
• Action: No quorum was present or represented at each session; business could not be transacted.
• Next steps: The company currently intends to seek stockholder approval of the proposals at a special meeting on a future date and will announce the date, time and location and provide proxy materials to be filed with the SEC and distributed to stockholders.

Why it may matter

• The filing reports Item 5.07: submission of matters to a vote of security holders, which covers the proposals that were to be considered and voted on at the Annual Meeting.
• This filing does not show why the insider traded or why the company acted.